Re: Freedman et al: Low- and very low-dose bevacizumab for retinopathy of prematurity: reactivations, additional treatments, and 12-month outcomes (Ophthalmology 2022;129:1120-1128)

被引：0

作者：

Asensio-Sanchez, Victor Manuel ^{[1
]}

机构：

[1] Clin Univ, Hosp Valladolid, Valladolid, Spain

来源：

关键词：

D O I：

10.1016/j.ophtha.2022.12.017

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：E18 / E18

页数：1

共 3 条

[1]

Early Treatment for Retinopathy of Prematurity Cooperative Group, 2003, Arch Ophthalmol, V121, P1684

Freedman, Sharon F. ;

Hercinovic, Amra ;

Wallace, David K. ;

Kraker, Raymond T. ;

Li, Zhuokai ;

Bhatt, Amit R. ;

Boente, Charline S. ;

Crouch, Eric R. ;

Hubbard, G. Baker ;

Rogers, David L. ;

VanderVeen, Deborah ;

Yang, Michael B. ;

Cheung, Nathan L. ;

Cotter, Susan A. ;

Holmes, Jonathan M. .

Wang, Jingyun ;

Ren, Xiaowei ;

Shen, Li ;

Yanni, Susan E. ;

Leffler, Joel N. ;

Birch, Eileen E. .